ADAMTS13 and Thrombocytopenia: Low baseline ADAMTS13 activity of 10%, regardless to detection of anti-ADAMTS13 autoantibodies, strongly supports the diagnosis of TTP in a patient with thrombocytopenia and microangiopathitic anemia providing that a detailed evaluation has ruled out other causes of thrombotic microangiopathy (13, 14).